BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Creative Medical Technology Holdings Expands Stem Cell Therapeutic Platform By Entry Into Field Of Stroke And Neurodegeneration

  Creative Medical Technology Holdings announced today filing of a patent application using a combination of an FDA approved drug together with the patient’s own bone marrow derived stem cells for the treatment of stroke.

  October 16, 2017

   · 

  4 min read
• Policy

  Eloxx Pharmaceuticals Announces Expansion Of Intellectual Property Estate For ELX-02 With Newly Granted Patent In Europe

  Sevion Therapeutics and Eloxx Pharmaceuticals announcedd that the European Patent Office (EPO) has granted a patent covering the Company’s lead product candidate, ELX-02, as well as other proprietary compounds.

  October 16, 2017

   · 

  3 min read
• Enzyvant Initiates Farber Disease Natural History Study

  Enzyvant, a biopharmaceutical company focused on developing innovative treatments for patients with rare diseases, today announced the initiation of the Farber Disease Natural History Study.

  October 16, 2017

   · 

  3 min read
• Drug Development

  BioAegis Hires Dr. Mark J. DiNubile as Chief Medical Officer to Spearhead Forthcoming Phase II Clinical Trials in Community-Acquired Pneumonia

  Dr. DiNubile brings to BioAegis the rare combination of clinical and research expertise along with broad pharmaceutical industry experience.

  October 16, 2017

   · 

  3 min read
• Business

  Dentsply Sirona Announces Additions to Executive Leadership Team

  Dentsply Sirona announced the appointment of two new Executive Leadership Team members, effective immediately.

  October 16, 2017

   · 

  5 min read
• Sirona Biochem To Present Kel-01 At Cosmetic 360 In Paris, France

  Sirona Biochem Corp. announced that Chief Scientific Officer, Dr. Geraldine Deliencourt-Godefroy, will attend and present on the trade floor at Cosmetic 360 in Paris, France on October 18-19, 2017.

  October 16, 2017

   · 

  2 min read
• 

  BioCapital

  Intrexon Enters Into $100M Preferred Stock Equity Facility

  Intrexon today announced that it has entered into a Preferred Stock Equity Facility with an affiliate of Third Security.

  October 16, 2017

   · 

  3 min read
• Drug Development

  PROMETRIKA To Coordinate Second Phase I Trial For MD Anderson’s Institute For Applied Cancer Science

  PROMETRIKA, LLC, a boutique full service Clinical Research Organization (CRO), is coordinating a Phase 1 trial for The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science.

  October 16, 2017

   · 

  1 min read
• Biotech Beach

  Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release And Conference Call

  Tandem Diabetes Care plans to release its third quarter 2017 results after the financial markets close on Thursday, October 26, 2017.

  October 16, 2017

   · 

  2 min read
• Business

  Senseonics Holdings, Inc. Schedules Third Quarter 2017 Earnings Release And Conference Call For October 31, 2017 At 4:30 P.M. Eastern Time

  Senseonics Holdings, Inc. today announced that it plans to release its third quarter 2017 financial results after market close on Tuesday, October 31, 2017.

  October 16, 2017

   · 

  1 min read